PepGen Inc., a clinical-stage biotechnology company, develops oligonucleotide therapeutics for the treatment of severe neuromuscular and neurologic diseases in the United States. The company engages in the development of PGN-EDODM1, an EDO ...
Leadership
James G. McArthur Ph.D.
President, CEO, Treasurer, Secretary & Director
Noel P. Donnelly M.B.A.
Chief Financial Officer
Joseph D. Vittiglio Esq., J.D.
Chief Business & Legal Officer and Secretary
Kasra Kasraian Ph.D.
Chief Technical Officer
Emiko Bryant
Senior Vice President of HR & Administration
Hayley Parker Ph.D.
Senior Vice President of Global Regulatory Affairs & Quality
Paul D. Streck M.B.A., M.D.
Executive VP and Head of Research & Development
Pallavi Lonkar Ph.D.
Vice President & Head of Preclinical
Melissa Michaels
Executive Director & Head of Regulatory Affairs CMC
